Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
Klatte T, Patard JJ, Wunderlich H, Goel RH, Lam JS, Junker K, Schubert J, Böhm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ.
Klatte T, et al. Among authors: pfister c.
J Urol. 2007 Jun;177(6):2081-6; discussion 2086-7. doi: 10.1016/j.juro.2007.01.122.
J Urol. 2007.
PMID: 17509291